Figure 5From: Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cellsEffect of anti-TLR4 antibody. (A-B) Western blotting and quantitative analysis of nuclear and cytoplasmic p65 after the use of TLR4-blocking antibody. (C) Relative MDR1 mRNA level and Rho-123 fluorescence ratio of DOX and PTX treated cells. *, p < 0.05; **, p < 0.01, blank, p > 0.05 (n = 3).Back to article page